WASHINGTON, DC—In the DanGer Shock trial of Impella CP (Abiomed) in patients with STEMI complicated by cardiogenic shock (STEMI-CS), bleeding occurs not just in the cath lab but also while on ...
Hemorrhagic shock can occur after losing a significant amount of blood. Both internal and external bleeding can cause it. Hemorrhagic shock is life threatening and requires immediate medical attention ...
WASHINGTON, DC—For patients who present with STEMI complicated by cardiogenic shock (STEMI-CS), it’s not news that the long-awaited DanGer Shock trial showed better 180-day survival after Impella CP ...
Extracorporeal life support (ECLS) is increasingly used in the treatment of infarct-related cardiogenic shock despite a lack of evidence regarding its effect on mortality. In this multicenter trial, ...
Recurrent bleeding from the small intestine accounts for 5 to 10% of cases of gastrointestinal bleeding and remains a therapeutic challenge. Thalidomide has been evaluated for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results